Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Integrating noncommunicable disease services into primary health care, Botswana.

Tapela NM, Tshisimogo G, Shatera BP, Letsatsi V, Gaborone M, Madidimalo T, Ovberedjo M, Jibril HB, Tsima B, Nkomazana O, Dryden-Peterson S, Lockman S, Masupe T, Hirschhorn LR, El Halabi S.

Bull World Health Organ. 2019 Feb 1;97(2):142-153. doi: 10.2471/BLT.18.221424. Epub 2019 Jan 8.

2.

Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer.

Tierney JF, Vale CL, Parelukar WR, Rydzewska L, Halabi S.

Eur Urol Focus. 2019 Jan 31. pii: S2405-4569(19)30005-7. doi: 10.1016/j.euf.2019.01.005. [Epub ahead of print] Review.

PMID:
30713089
3.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Mangat PK, Halabi S, Bruinooge SS, Garrett-Mayer E, Alva A, Janeway KA, Stella PJ, Voest E, Yost KJ, Perlmutter J, Pinto N, Kim ES, Schilsky RL.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00122. Epub 2018 Jul 11.

4.

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, Araujo JC, Logothetis C, Quinn DI, Fizazi K, Morris MJ, Eisenberger MA, George DJ, De Bono JS, Higano CS, Tannock IF, Small EJ, Kelly WK.

J Clin Oncol. 2019 Feb 10;37(5):403-410. doi: 10.1200/JCO.18.01279. Epub 2018 Dec 21.

PMID:
30576268
5.

Deep-learning-assisted diagnosis for knee magnetic resonance imaging: Development and retrospective validation of MRNet.

Bien N, Rajpurkar P, Ball RL, Irvin J, Park A, Jones E, Bereket M, Patel BN, Yeom KW, Shpanskaya K, Halabi S, Zucker E, Fanton G, Amanatullah DF, Beaulieu CF, Riley GM, Stewart RJ, Blankenberg FG, Larson DB, Jones RH, Langlotz CP, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 27;15(11):e1002699. doi: 10.1371/journal.pmed.1002699. eCollection 2018 Nov.

6.

The RSNA Pediatric Bone Age Machine Learning Challenge.

Halabi SS, Prevedello LM, Kalpathy-Cramer J, Mamonov AB, Bilbily A, Cicero M, Pan I, Pereira LA, Sousa RT, Abdala N, Kitamura FC, Thodberg HH, Chen L, Shih G, Andriole K, Kohli MD, Erickson BJ, Flanders AE.

Radiology. 2019 Feb;290(2):498-503. doi: 10.1148/radiol.2018180736. Epub 2018 Nov 27.

PMID:
30480490
7.

Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.

Rajpurkar P, Irvin J, Ball RL, Zhu K, Yang B, Mehta H, Duan T, Ding D, Bagul A, Langlotz CP, Patel BN, Yeom KW, Shpanskaya K, Blankenberg FG, Seekins J, Amrhein TJ, Mong DA, Halabi SS, Zucker EJ, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 20;15(11):e1002686. doi: 10.1371/journal.pmed.1002686. eCollection 2018 Nov.

8.

Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes.

Pi L, Halabi S.

Diagn Progn Res. 2018;2. pii: 21. doi: 10.1186/s41512-018-0043-4. Epub 2018 Sep 26.

9.

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, Sanford BL, Eastham JA, Walther PJ, Morris MJ, Small EJ.

Prostate Cancer Prostatic Dis. 2018 Nov 1. doi: 10.1038/s41391-018-0106-1. [Epub ahead of print]

PMID:
30385835
10.

Migrating to the Modern PACS: Challenges and Opportunities.

Berkowitz SJ, Wei JL, Halabi S.

Radiographics. 2018 Oct;38(6):1761-1772. doi: 10.1148/rg.2018180161.

PMID:
30303805
11.

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 Nov;103:287. doi: 10.1016/j.ejca.2018.09.022. Epub 2018 Sep 27. No abstract available.

12.

Power matters: The role of power and morality needs in competitive victimhood among advantaged and disadvantaged groups.

Kahalon R, Shnabel N, Halabi S, SimanTov-Nachlieli I.

Br J Soc Psychol. 2018 Aug 29. doi: 10.1111/bjso.12276. [Epub ahead of print]

PMID:
30156303
13.

Off-Label Marketing's Audiences: The 21st Century Cures Act and the Relaxation of Standards for Evidence-Based Therapeutic and Cost-Comparative Claims.

Halabi SF.

Am J Law Med. 2018 May;44(2-3):181-196. doi: 10.1177/0098858818789420. No abstract available.

PMID:
30106659
14.

Improving Door-to-Balloon Time of Patients with ST-Segment Elevation Myocardial Infarction (STEMI) in the Emergency Department.

Halabi S, Elias A, Goldberg M, Hurani H, Darawsha H, Shachar S, Ashkenazi M.

Isr Med Assoc J. 2018 Aug;20(8):476-479.

15.

The association between cardiovascular disease gene mutations and recurrent pregnancy loss in the Lebanese population.

El Achi H, Awwad J, Abou Daya S, Halabi S, Damianos S, Mahfouz R.

Mol Biol Rep. 2018 Oct;45(5):911-916. doi: 10.1007/s11033-018-4237-1. Epub 2018 Jul 4.

PMID:
29974397
16.

Future time perspective and interpersonal empathy: Implications for preferring autonomy- versus dependency-oriented helping.

Chernyak-Hai L, Halabi S.

Br J Soc Psychol. 2018 Oct;57(4):793-814. doi: 10.1111/bjso.12260. Epub 2018 Jun 21.

PMID:
29926924
17.

Health Data and Privacy in the Digital Era.

Gostin LO, Halabi SF, Wilson K.

JAMA. 2018 Jul 17;320(3):233-234. doi: 10.1001/jama.2018.8374. No abstract available.

PMID:
29926092
18.

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL.

Clin Cancer Res. 2018 Oct 1;24(19):4734-4744. doi: 10.1158/1078-0432.CCR-17-1523. Epub 2018 Jun 5.

PMID:
29871907
19.

Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.

Al Halabi S, Newman J, Farkouh ME, Fortuin D, Leya F, Sweeney J, Darki A, Lopez J, Steen L, Lewis B, Webb J, Leon MB, Mathew V.

Am J Cardiol. 2018 Jul 1;122(1):141-148. doi: 10.1016/j.amjcard.2018.03.019. Epub 2018 Mar 28.

PMID:
29779587
20.

Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.

Novitsky V, Gaolathe T, Mmalane M, Moyo S, Chakalisa U, Yankinda EK, Marukutira T, Holme MP, Sekoto T, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis KM, Khan N, Dryden-Peterson S, Bennett K, Wirth KE, Tchetgen ET, Bachanas P, Mills LA, Lebelonyane R, El-Halabi S, Makhema J, Lockman S, Essex M.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715.

PMID:
29771781
21.

Comparison of air exhausts for surgical body suits (space suits) and the potential for periprosthetic joint infection.

Ling F, Halabi S, Jones C.

J Hosp Infect. 2018 Jul;99(3):279-283. doi: 10.1016/j.jhin.2018.03.012. Epub 2018 Mar 17.

PMID:
29559232
22.

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 May;94:115-125. doi: 10.1016/j.ejca.2018.02.012. Epub 2018 Mar 20. Erratum in: Eur J Cancer. 2018 Nov;103:287.

23.

Data Science: Big Data, Machine Learning, and Artificial Intelligence.

Carlos RC, Kahn CE, Halabi S.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):497-498. doi: 10.1016/j.jacr.2018.01.029. No abstract available. Erratum in: J Am Coll Radiol. 2018 May;15(5):819.

PMID:
29502583
24.

Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 1: From Methodology to Clinical Implementation.

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):538-542. doi: 10.1016/j.jacr.2017.12.008. Epub 2018 Feb 1. Review.

PMID:
29366600
25.

Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise.

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):543-549. doi: 10.1016/j.jacr.2017.12.006. Epub 2018 Feb 1. Review.

PMID:
29366598
26.

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.

Anderson K, Ismaila N, Flynn PJ, Halabi S, Jagannath S, Ogaily MS, Omel J, Raje N, Roodman GD, Yee GC, Kyle RA.

J Clin Oncol. 2018 Mar 10;36(8):812-818. doi: 10.1200/JCO.2017.76.6402. Epub 2018 Jan 17.

PMID:
29341831
27.

A Simple Method for Deriving the Confidence Regions for the Penalized Cox's Model via the Minimand Perturbation.

Lin CY, Halabi S.

Commun Stat Theory Methods. 2017;46(10):4791-4808. doi: 10.1080/03610926.2015.1085568. Epub 2016 May 18.

28.

Effect of N-Acetylserotonin on TLR-4 and MyD88 Expression during Intestinal Ischemia-Reperfusion in a Rat Model.

Sukhotnik I, Ben Shahar Y, Halabi S, Bitterman N, Dorfman T, Pollak Y, Coran A, Bitterman A.

Eur J Pediatr Surg. 2018 Jan 5. doi: 10.1055/s-0037-1618593. [Epub ahead of print]

PMID:
29304519
30.

Performance of a Deep-Learning Neural Network Model in Assessing Skeletal Maturity on Pediatric Hand Radiographs.

Larson DB, Chen MC, Lungren MP, Halabi SS, Stence NV, Langlotz CP.

Radiology. 2018 Apr;287(1):313-322. doi: 10.1148/radiol.2017170236. Epub 2017 Nov 2.

PMID:
29095675
31.

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI.

Ann Oncol. 2018 Jan 1;29(1):23-25. doi: 10.1093/annonc/mdx648. No abstract available.

32.

Technical Challenges in the Clinical Application of Radiomics.

Shaikh FA, Kolowitz BJ, Awan O, Aerts HJ, von Reden A, Halabi S, Mohiuddin SA, Malik S, Shrestha RB, Deible C.

JCO Clin Cancer Inform. 2017 Nov;1:1-8. doi: 10.1200/CCI.17.00004.

33.

An Intervention to Reduce the Time Interval Between Hospital Entry and Emergency Coronary Angiography in Patients with ST-Elevation Myocardial Infarction.

Karkabi B, Jaffe R, Halon DA, Merdler A, Khader N, Rubinshtein R, Goldstein J, Zafrir B, Zissman K, Ben-Dov N, Gabrielly M, Fuks A, Shiran A, Adawi S, Hellman Y, Shahla J, Halabi S, Flugelman MY, Cohen S, Bergman I, Kassem S, Shapira C.

Isr Med Assoc J. 2017 Sep;19(9):547-552.

34.

Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.

Beltran H, Wyatt AW, Chedgy EC, Donoghue A, Annala M, Warner EW, Beja K, Sigouros M, Mo F, Fazli L, Collins CC, Eastham J, Morris M, Taplin ME, Sboner A, Halabi S, Gleave ME.

Clin Cancer Res. 2017 Nov 15;23(22):6802-6811. doi: 10.1158/1078-0432.CCR-17-1034. Epub 2017 Aug 25.

35.

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Clarke NW, Collette L, Dignam JJ, Fizazi K, Paruleker WR, Sandler HM, Sydes MR, Tombal B, Williams SG, Sweeney CJ; ICECaP Working Group.

J Clin Oncol. 2017 Sep 20;35(27):3097-3104. doi: 10.1200/JCO.2017.73.9987. Epub 2017 Aug 10.

36.

Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.

Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA.

J Surg Oncol. 2017 Dec;116(8):969-982. doi: 10.1002/jso.24774. Epub 2017 Aug 2. Review.

37.

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Borges Dos Reis R, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A.

Eur Urol. 2018 Feb;73(2):178-211. doi: 10.1016/j.eururo.2017.06.002. Epub 2017 Jun 24.

38.

Reply to B. Rini et al and S. Buti et al.

Choueiri TK, Halabi S, Morris MJ, George D.

J Clin Oncol. 2017 Jun 1;35(16):1859-1860. doi: 10.1200/JCO.2017.72.2629. Epub 2017 Mar 6. No abstract available.

PMID:
28549224
39.

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.

Armstrong AJ, Halabi S, Healy P, Alumkal JJ, Winters C, Kephart J, Bitting RL, Hobbs C, Soleau CF, Beer TM, Slottke R, Mundy K, Yu EY, George DJ.

Eur J Cancer. 2017 Aug;81:228-236. doi: 10.1016/j.ejca.2017.02.030. Epub 2017 May 11.

40.

Legal Complexities of Global Vaccine Compensation Systems-Reply.

Halabi SF, Omer SB.

JAMA. 2017 May 9;317(18):1912. doi: 10.1001/jama.2017.4432. No abstract available.

PMID:
28492896
41.

Evaluating the Effect of Unstructured Clinical Information on Clinical Decision Support Appropriateness Ratings.

Moriarity AK, Green A, Klochko C, O'Brien M, Halabi S.

J Am Coll Radiol. 2017 Jun;14(6):737-743. doi: 10.1016/j.jacr.2017.02.003. Epub 2017 Apr 21.

PMID:
28434848
42.

Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis: a meta-analysis.

Sawas T, Arwani N, Al Halabi S, Vargo J.

Endosc Int Open. 2017 Feb;5(2):E103-E109. doi: 10.1055/s-0042-120412.

43.

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

Choueiri TK, Halabi S, Sanford BL, Hahn O, Michaelson MD, Walsh MK, Feldman DR, Olencki T, Picus J, Small EJ, Dakhil S, George DJ, Morris MJ.

J Clin Oncol. 2017 Feb 20;35(6):591-597. doi: 10.1200/JCO.2016.70.7398. Epub 2016 Nov 14.

44.

A Global Vaccine Injury Compensation System.

Halabi SF, Omer SB.

JAMA. 2017 Feb 7;317(5):471-472. doi: 10.1001/jama.2016.19492. No abstract available.

PMID:
28114657
45.

Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome.

Halabi S, Sekine E, Verstak B, Gay NJ, Moncrieffe MC.

J Biol Chem. 2017 Jan 13;292(2):652-660. doi: 10.1074/jbc.M116.761528. Epub 2016 Dec 1.

46.

Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.

Armstrong AJ, Humeniuk MS, Healy P, Szmulewitz R, Winters C, Kephart J, Harrison MR, Martinez E, Mundy K, Halabi S, George D.

Prostate. 2017 Mar;77(4):385-395. doi: 10.1002/pros.23277. Epub 2016 Nov 16.

47.

Accelerated intestinal epithelial cell turnover after bowel resection in a rat is correlated with inhibited hedgehog signaling cascade.

Sukhotnik I, Dorfman T, Halabi S, Pollak Y, Kreizman Shefer H, Coran AG, Berkowitz D.

Pediatr Surg Int. 2016 Dec;32(12):1133-1140. Epub 2016 Sep 19.

PMID:
27644702
48.

High Dimensional Variable Selection with Error Control.

Kim S, Halabi S.

Biomed Res Int. 2016;2016:8209453. doi: 10.1155/2016/8209453. Epub 2016 Aug 15.

49.

Comparison of futility monitoring guidelines using completed phase III oncology trials.

Zhang Q, Freidlin B, Korn EL, Halabi S, Mandrekar S, Dignam JJ.

Clin Trials. 2017 Feb;14(1):48-58. doi: 10.1177/1740774516666502. Epub 2016 Sep 22.

50.

Effect of Chelerythrine on Intestinal Cell Turnover following Intestinal Ischemia-Reperfusion Injury in a Rat Model.

Sukhotnik I, Bitterman S, Shahar YB, Pollak Y, Bitterman N, Halabi S, Coran AG, Bitterman A.

Eur J Pediatr Surg. 2017 Feb;27(1):36-43. doi: 10.1055/s-0036-1587588. Epub 2016 Aug 14.

PMID:
27522123

Supplemental Content

Loading ...
Support Center